Long-term outcome of kidney function in patients with ANCA-associated vasculitis

被引:7
|
作者
Sachez-Alamo, Beatriz [1 ,2 ]
Moi, Laura [3 ]
Bajema, Ingeborg [4 ]
Berden, Annelies [5 ]
Flossmann, Oliver [6 ]
Hruskova, Zdenka [7 ]
Jayne, David [8 ]
Wester-Trejo, Maria [9 ]
Wallquist, Carin [10 ]
Westman, Kerstin [11 ]
机构
[1] Lund Univ, Dept Clin Sci Lund, Div Nephrol, Lund, Sweden
[2] Hosp Univ Sureste, Dept Nephrol, Madrid, Spain
[3] Univ Hosp Lausanne, Lausanne Univ, Dept Med, Div Immunol & Allergy, Lausanne, Switzerland
[4] Dept Pathol, Groningen, Netherlands
[5] Maasstad Hosp, Dept Rheumatol & Clin Immunol, Rotterdam, Netherlands
[6] Royal Berkshire Hosp, Dept Nephrol, Reading, England
[7] Charles Univ Prague, Gen Hosp Prague, Fac Med 1, Dept Nephrol, Prague, Czech Republic
[8] Univ Cambridge, Dept Med, Cambridge, England
[9] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands
[10] Skane Univ, Hosp Malmo, Dept Nephrol, Malmo, Sweden
[11] Lund Univ, Dept Clin Sci Lund, Div Nephrol, Lund, Sweden
关键词
ANCA-associated vasculitis; end-stage kidney disease; kidney histology scores; prognosis; transplantation; ANTIBODY-ASSOCIATED VASCULITIS; HISTOPATHOLOGICAL CLASSIFICATION; SPANISH REGISTRY; RENAL VASCULITIS; GLOMERULONEPHRITIS; BIOPSY; SURVIVAL; PROPOSAL; WEGENER; TRIALS;
D O I
10.1093/ndt/gfae018
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Kidney involvement is common in anti-neutrophil cytoplasm antibody-associated vasculitis (AAV) and the prognosis is determined by the severity of kidney damage. This study focused on long-term kidney outcomes, defining possible risk factors and comparing the performance of three different histological classifications to predict outcomes for patients with AAV. Methods. The dataset included 848 patients with newly diagnosed AAV who participated in seven randomized controlled trials (RCTs) (1995-2012). Follow-up information was obtained from questionnaires sent to the principal investigators of the original RCTs. Results. The cumulative incidence of end-stage kidney disease (ESKD) at 5 and 10 years was 17% and 22%, respectively. Patients who developed ESKD had reduced patient survival compared with those with preserved kidney function (hazard ratio 2.8, P < .001). Comparing patients with AAV and kidney involvement with a matched general population, patients with AAV had poor survival outcomes, even in early stages of chronic kidney disease. The main cause of death was infection followed by cardiovascular disease in patients developing ESKD and malignancy in those who did not. Some 34% of patients with initial need for dialysis recovered kidney function after treatment. Thirty-five out of 175 in need of kidney replacement therapy (KRT) during follow-up received a kidney transplant with good outcome; there was 86% patient survival at 10 years. In the subcohort of 214 patients with available kidney biopsies, three scoring systems were tested: the Berden classification, the Renal Risk Score and the Mayo Clinic Score. The scores highlighted the importance of normal glomeruli and severe glomerulosclerosis on kidney survival (P < .001 and P = .001, respectively). The Renal Risk Score demonstrated a moderate prediction of kidney survival (area under the curve 0.79; standard error 0.03, 95% confidence interval 0.71-0.83). Conclusions Early diagnosis of AAV is extremely important. Even milder forms of kidney involvement have an impact on the prognosis. Patients in need of KRT had the lowest survival rates, but kidney transplantation has shown favorable outcomes for eligible AAV patients. The three histologic scoring systems were all identified as independent prognostic factors for kidney outcome.
引用
收藏
页码:1483 / 1493
页数:11
相关论文
共 50 条
  • [41] Relapse rate and renal prognosis in ANCA-associated vasculitis according to long-term ANCA patterns
    Oristrell, J.
    Loureiro-Amigo, J.
    Solans, R.
    Valenzuela, M. P.
    Monsalvez, V.
    Segarra, A.
    Amengual, M. J.
    Marin, A.
    Feijoo, C.
    Tolosa, C.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2021, 203 (02): : 209 - 218
  • [42] PULMONARY FIBROSIS IN ANCA-ASSOCIATED VASCULITIS: CLINICAL CHARACTERISTICS AND LONG-TERM FOLLOWUP OF 49 PATIENTS
    Comarmond, C.
    Crestani, B.
    Tazi, A.
    Hervier, B.
    Marchand, S. Adam
    Nunes, H.
    Cohen-Aubart, F.
    Wislez, M.
    Cadranel, J.
    Housset, B.
    Lloret-Linares, C.
    Seve, P.
    Pagnoux, C.
    Abad, S.
    Camuset, J.
    Bienvenu, B.
    Duruisseaux, M.
    Hachulla, E.
    Arlet, J. -B.
    Hamidou, M.
    Mahr, A.
    Resche-Rigon, M.
    Brun, A. -L.
    Grenier, P.
    Cacoub, P.
    Saadoun, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 553 - 554
  • [43] Predictors of long-term (≥ 5 year) renal survival in 535 patients with ANCA-associated vasculitis
    Berden, Annelies
    Flossmann, Oliver
    Westman, Kerstin
    Hoglund, Peter
    Hagen, E. Christiaan
    le Cessie, Saskia
    Walsh, Michael
    Bruijn, Jan Anthonie
    Jayne, David
    Bajema, Ingeborg
    APMIS, 2009, 117 : 150 - 150
  • [44] Clinical and histological determinants of long-term outcome in ANCA-associated glomerulonephritis
    de Lind, van Wijngaarden R. A. F.
    Hauer, H. A.
    Flossmann, O.
    Jayne, D. R. W.
    Westman, K. W.
    Gaskin, G.
    Rasmussen, N.
    Noel, L. -H.
    Ferrarici, F.
    Waldherr, R.
    Hagen, E. C.
    Bruijn, J. A.
    Bajema, I. M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (01) : S115 - S115
  • [45] OUTCOME AND IMMUNOSUPPRESSIVE TREATMENT OF ELDERLY PATIENTS WITH ANCA-ASSOCIATED VASCULITIS
    Kato, Akiko
    Ito, Eri
    Kamegai, Naoki
    Mizutani, Minami
    Shimogushi, Hiroya
    Tanaka, Akihito
    Shinjo, Hibiki
    Otsuka, Yasuhiro
    Inaguma, Daijo
    Takeda, Asami
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 382 - 383
  • [46] Outcome and prognostic factors in elderly patients with ANCA-associated vasculitis
    Weiner, M.
    Goh, S. M.
    Mohammad, A.
    Hruskova, Z.
    Tanna, A.
    Bruchfeld, A.
    Selga, D.
    Ko, Q.
    Westman, K.
    Eriksson, P.
    Pusey, C.
    Tesar, V.
    Salama, A.
    Segelmark, M.
    PRESSE MEDICALE, 2013, 42 (04): : 674 - 674
  • [47] LONG-TERM RENAL SURVIVAL OF ANCA-ASSOCIATED VASCULITIS PATIENTS INCLUDED IN THE EUVAS RANDOMIZED CLINICAL TRIALS
    Alamo, Beatriz Sanchez
    Moi, Laura
    Bajema, Ingeborg M.
    Hruskova, Zdenka
    Jayne, David
    Westman, Kerstin W. A.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I824 - I825
  • [48] LONG-TERM PATIENT SURVIVAL AND CLUSTER ANALYSIS IN A SWEDISH COHORT OF CONSECUTIVE PATIENTS WITH ANCA-ASSOCIATED VASCULITIS
    Heijl, Caroline
    Mohammad, Aladdin A. C.
    Westman, Kerstin
    Hoglund, Peter
    RHEUMATOLOGY, 2017, 56 : 104 - 104
  • [49] LONG-TERM MAINTENANCE TREATMENT WITH RITUXIMAB IN ANCA-ASSOCIATED VASCULITIS: A RETROSPECTIVE COHORT STUDY
    Chalkia, Aglaia
    Thomas, Konstantinos
    Kourniotis, Dimitrios
    Panagiotopoulos, Alexandros
    Alexakou, Zoe
    Mpora, Margarita
    Aggelis, George
    Vasilopoulos, Dimitrios
    Petras, Dimitrios
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [50] Long-term maintenance rituximab for ANCA-associated vasculitis: relapse and infection prediction models
    McClure, Mark E.
    Zhu, Yajing
    Smith, Rona M.
    Gopaluni, Seerapani
    Tieu, Joanna
    Pope, Tasneem
    Kristensen, Karl Emil
    Jayne, David R. W.
    Barrett, Jessica
    Jones, Rachel B.
    RHEUMATOLOGY, 2021, 60 (03) : 1491 - 1501